Found 11 matching trials
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM NA To test the effectiveness and safety of Optune® given concomitantly with ra...
Show More Location
Grandview Cancer Center
Learn More & Join Trial
Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation NA The purpose of the study is to assess timing of TTFields use as well as saf...
Show More Location
University Hospital of Heidelberg, Radiation Oncology
Learn More & Join Trial
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma PHASE2 This study consists of 2 portions. The phase 2 portion is an open-label, si...
Show More Status
Active Not Recruiting
Location
Chan Soon-Shiong Institute for Medicine (CSSIFM)
Learn More & Join Trial
Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP) PHASE2 Glioblastoma multiforme (GBM) is the most common and deadliest primary mali...
Show More Status
Active Not Recruiting
Location
University of Florida Health
Learn More & Join Trial
Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma PHASE2 This phase II trial will investigate the efficacy and safety of the additio...
Show More Location
University of California, San Diego
Learn More & Join Trial
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma PHASE3 This is a multicenter, two-arm, randomized, double-blind, placebo-controlle...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma PHASE1 The purpose of this study is to use precision medicine in the form of a vac...
Show More Status
Active Not Recruiting
Location
Albert Einstein College of Medicine
Learn More & Join Trial
Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM PHASE2 This is a prospective, open-label, single arm, historical control pilot stu...
Show More Location
Nemocnice Na Homolce
Learn More & Join Trial
FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma PHASE2 This is a phase 2, multi-institutional, historically-controlled, study of 1...
Show More Location
UF Health at the University of Florida
Learn More & Join Trial
OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial PHASE2 In this study we are evaluating the safety and feasibility of the triple co...
Show More Location
UF Health Shands Hospital
Learn More & Join Trial